Squarepoint
GRTS

Squarepoint’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Squarepoint’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-64,929
Closed -$40.1K – 4821
2024
Q2 		$40.1K Buy
+64,929
New +$54.9K ﹤0.01% 3929
2024
Q1 		– Sell
-23,085
Closed -$47.1K – 4742
2023
Q4 		$47.1K Sell
23,085
-29,855
-56% -$54.5K ﹤0.01% 3854
2023
Q3 		$91.1K Buy
+52,940
New +$94K ﹤0.01% 3572
2023
Q2 		– Sell
-59,308
Closed -$165K – 4121
2023
Q1 		$165K Buy
+59,308
New +$169K ﹤0.01% 2863
2022
Q2 		– Sell
-70,284
Closed -$290K – 3510
2022
Q1 		$290K Buy
70,284
+3,579
+5% +$19K ﹤0.01% 2302
2021
Q4 		$858K Buy
66,705
+31,656
+90% +$351K ﹤0.01% 1792
2021
Q3 		$379K Buy
35,049
+7,483
+27% +$68.1K ﹤0.01% 2127
2021
Q2 		$252K Sell
27,566
-1,112
-4% -$10.3K ﹤0.01% 2653
2021
Q1 		$270K Sell
28,678
-3,494
-11% -$48.1K ﹤0.01% 2481
2020
Q4 		$127K Buy
+32,172
New +$97.3K ﹤0.01% 2666
2020
Q3 		– Sell
-68,410
Closed -$454K – 2916
2020
Q2 		$454K Buy
68,410
+39,652
+138% +$267K 0.01% 1363
2020
Q1 		$167K Buy
+28,758
New +$241K ﹤0.01% 1535
2019
Q2 		– Sell
-11,942
Closed -$159K – 2733
2019
Q1 		$159K Sell
11,942
-16,788
-58% -$224K ﹤0.01% 1983
2018
Q4 		$444K Buy
+28,730
New +$548K 0.01% 1314

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Squarepoint's GRTS Position: Q3 2024 in Review

Squarepoint sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 64,929 shares — an estimated $40.1K sold.

Squarepoint first reported a position in GRTS in Q4 2018 and held it in 14 quarters. The position peaked at $858K in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Squarepoint reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Squarepoint sold 64,929 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $40.1K.
  • Squarepoint first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • Squarepoint's Gritstone bio, Inc. Common Stock position peaked at $858K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.